Literature DB >> 1833072

Possible mechanism of the preventive effect of BCG against diabetes mellitus in NOD mouse. I. Generation of suppressor macrophages in spleen cells of BCG-vaccinated mice.

H Yagi1, M Matsumoto, S Suzuki, R Misaki, R Suzuki, S Makino, M Harada.   

Abstract

With the aim of clarifying the mechanism of the suppressive action of BCG against insulitis and overt diabetes in NOD mice, we studied the effects of BCG on spleen cell populations and on the in vitro immune responses of spleen cells. The spleen cells of BCG-vaccinated mice showed much lower responsiveness to various mitogens such as Con A, PHA, PWM, and LPS than those of saline-treated mice. Low responsiveness to alloantigens was also observed. Flow cytometric analysis of the spleen cells revealed that Mac-1+ and Mac-2+ cells had increased while T and B cells had decreased in the BCG-vaccinated mice compared with the saline-treated mice at the time when the maximum level of inhibition of mitogen responses of BCG-vaccinated mice was observed. This suggests that the decreased in vitro immune response was due to the increase in macrophages which suppress lymphocyte functions. Support for this interpretation comes from the following two findings: (1) the restoration of mitogen responses of spleen cells when macrophages were eliminated by plastic adhesion or FACS sorting and (2) resuppression of PHA and Con A responses of plastic-nonadherent spleen cells by addition of adherent cells or flow cytometrically sorted Mac-1+ cells obtained from BCG-vaccinated mice. These results indicate the generation of suppressor macrophages after BCG vaccination and suggest that these macrophages prevent the autoimmune pathogenesis leading to diabetes in NOD mice.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1833072     DOI: 10.1016/0008-8749(91)90138-2

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  8 in total

Review 1.  Strategies for preventing type I diabetes mellitus.

Authors:  C F Verge; G S Eisenbarth
Journal:  West J Med       Date:  1996-03

2.  Diabetes-prone NOD mice are resistant to Mycobacterium avium and the infection prevents autoimmune disease.

Authors:  A Brás; A P Aguas
Journal:  Immunology       Date:  1996-09       Impact factor: 7.397

3.  Prevention of diabetes mellitus in non-obese diabetic mice by Linomide, a novel immunomodulating drug.

Authors:  D J Gross; H Sidi; L Weiss; T Kalland; E Rosenmann; S Slavin
Journal:  Diabetologia       Date:  1994-12       Impact factor: 10.122

4.  Mycobacterium bovis bacille Calmette-Guérin infection in the CNS suppresses experimental autoimmune encephalomyelitis and Th17 responses in an IFN-gamma-independent manner.

Authors:  JangEun Lee; Emily K Reinke; Alla L Zozulya; Matyas Sandor; Zsuzsanna Fabry
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

5.  Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice.

Authors:  A G Baxter; A C Horsfall; D Healey; P Ozegbe; S Day; D G Williams; A Cooke
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397

6.  A protective role of gamma delta T cells in primary infection with Listeria monocytogenes in autoimmune non-obese diabetic mice.

Authors:  J Usami; K Hiromatsu; Y Matsumoto; K Maeda; H Inagaki; T Suzuki; Y Yoshikai
Journal:  Immunology       Date:  1995-10       Impact factor: 7.397

7.  Hypoglycemic and hypolipidemic effects of polyphenols from burs of Castanea mollissima Blume.

Authors:  Peipei Yin; Shan Zhao; Siyu Chen; Jieyuan Liu; Lingling Shi; Xinjie Wang; Yujun Liu; Chao Ma
Journal:  Molecules       Date:  2011-11-24       Impact factor: 4.411

8.  Therapeutic Effects of BCG Vaccination on Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Yu-Chen Chang; Chien-Ju Lin; Yu-Hsuan Hsiao; Yu-Han Chang; Shu-Jung Liu; Hsin-Yin Hsu
Journal:  J Diabetes Res       Date:  2020-03-26       Impact factor: 4.011

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.